Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06914037
What this trial is testing

A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma)
Tianjin Medical University Cancer Institute and Hospital 24
Large-scale testing (Phase 3)Study completedNCT02561039
What this trial is testing

Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 97
Post-approval studies (Phase 4)UnknownNCT00838019
What this trial is testing

Intrabone Cord Blood Transplantation

Who this might be right for
Hematological Malignancies
Hospital Clinic of Barcelona 10
Not applicableLooking for participantsNCT06785077
What this trial is testing

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Who this might be right for
Leukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer
European Institute of Oncology 157
Testing effectiveness (Phase 2)Study completedNCT00603954
What this trial is testing

Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

Who this might be right for
Hematological Malignancies
University of Liege 107
Not applicableStudy completedNCT05819762
What this trial is testing

Evaluation of ClearLLab LS Screening Panel

Who this might be right for
Hematologic MalignancyHematologic NeoplasmsHematologic Diseases
Beckman Coulter, Inc. 831
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Not applicableStudy completedNCT05101759
What this trial is testing

Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy

Who this might be right for
Neoplasm, Plasma CellLymphoma
University Hospital, Toulouse 100
Not applicableNot Yet RecruitingNCT07483749
What this trial is testing

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaLymphoma+2 more
The Children's Hospital of Zhejiang University School of Medicine 400
Early research (Phase 1)Study completedNCT00458250
What this trial is testing

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Tehran University of Medical Sciences 10
Testing effectiveness (Phase 2)UnknownNCT06066255
What this trial is testing

PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 27
Early research (Phase 1)Study completedNCT01853358
What this trial is testing

Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 17
Very early researchLooking for participantsNCT04532281
What this trial is testing

Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft Tissue
Zhejiang University 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05944978
What this trial is testing

GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies

Who this might be right for
Relapsed/Refractory Chronic Lymphocytic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 3
Not applicableStudy completedNCT01092026
What this trial is testing

Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells

Who this might be right for
Allogeneic Stem Cell Transplantation
Universitair Ziekenhuis Brussel 11
Early research (Phase 1)Active Not RecruitingNCT05347225
What this trial is testing

Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Who this might be right for
Hematological Malignancies
Merck Sharp & Dohme LLC 12
Not applicableNot Yet RecruitingNCT07541326
What this trial is testing

Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 85
Very early researchUnknownNCT05239689
What this trial is testing

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

Who this might be right for
AML
Zhejiang University 36
Testing effectiveness (Phase 2)Looking for participantsNCT03850366
What this trial is testing

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Who this might be right for
Hematological Malignancy
Henry Ford Health System 15
Not applicableLooking for participantsNCT04733729
What this trial is testing

Covid-19 in Hematological Malignancies

Who this might be right for
COVID-19 Infection in Hematological Malignancies Patients
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 3,000
Next Page